State of the science in cervical cancer: Where we are today and where we need to go

导出原文传递

翻译打印收藏纠错

作者： Dizon,D.S. ^[1] ; Mackay,H.J. ^[2] ; Thomas,G.M. ^[3] ; Werner,T.L. ^[4] ; Kohn,E.C. ^[5] ; Hess,D. ^[6] ; Rose,P.G. ^[7] ; Covens,A.L. ^[8]

作者单位： Gynecologic Cancer Therapeutics, Division of Cancer Treatment and Diagnosis, National Cancer ^[1] National Cancer Institute Gynecologic Oncology Steering Committees, EMMES Corporation, Rockville ^[2] Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic ^[3] Division of Oncology, Department of Medicine, University of Utah School of Medicine, Salt Lake City ^[4] Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Center, University of Toronto ^[5] Gillette Center for Gynecologic Oncology, Massachusetts General Hospital Cancer Center, 55 Fruit St ^[6] Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto ^[7] Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada ^[8]

关键词 anti-angiogenesis cervical cancer clinical trials human papillomavirus immunotherapy prevention screening

发布时间 2015-02-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交